Correlation Between Pieris Pharmaceuticals and Revolution Medicines

Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pieris Pharmaceuticals and Revolution Medicines, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Revolution Medicines.

Diversification Opportunities for Pieris Pharmaceuticals and Revolution Medicines

-0.45

Correlation Coefficient

Pieris Pharmaceuticals  Revolution Medicines

Very good diversification

The 3 months correlation between Pieris and Revolution is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Revolution Medicines go up and down completely randomly.

Pair Corralation between Pieris Pharmaceuticals and Revolution Medicines

Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the Revolution Medicines. But the stock apears to be less risky and, when comparing its historical volatility, Pieris Pharmaceuticals is 1.27 times less risky than Revolution Medicines. The stock trades about -0.06 of its potential returns per unit of risk. The Revolution Medicines is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  4,263  in Revolution Medicines on August 30, 2024 and sell it today you would earn a total of  1,595  from holding Revolution Medicines or generate 37.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Pieris Pharmaceuticals  vs.  Revolution Medicines

Pieris Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Revolution Medicines

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pieris Pharmaceuticals and Revolution Medicines

The main advantage of trading using opposite Pieris Pharmaceuticals and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.

The idea behind Pieris Pharmaceuticals and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.